Mizuki Yamada
Overview
Explore the profile of Mizuki Yamada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
537
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sato K, Okada T, Okada R, Yasui H, Yamada M, Isobe Y, et al.
ACS Nano
. 2025 Feb;
19(8):8338-8356.
PMID: 39964399
Near-infrared photoimmunotherapy (NIR-PIT) is a cancer treatment modality that uses antibody-photoabsorber (IR700) conjugates to destroy specific cells. The reaction between the antibody and photoabsorber is triggered by NIR-light, and this...
2.
Inoue Y, Okamura K, Shimada H, Watakabe S, Hirayama S, Hirata M, et al.
J Clin Med Res
. 2025 Jan;
16(12):578-588.
PMID: 39759487
Background: Our hospital is a designated emergency hospital and accepts many patients with out-of-hospital cardiac arrest (OHCA). Previously, after receiving a direct call from emergency services to request acceptance of...
3.
Yamada M, Gam H, Ikegami N, Nishikawa Y, Ishikawa A, Funaki A, et al.
Front Physiol
. 2023 Nov;
14:1294284.
PMID: 38028805
Testosterone replacement therapy (TRT) in transgender men (TM) results in side effects such as elevated triglycerides and increased arterial stiffness. Exercise may be useful to ameliorate such effects, but no...
4.
Ishikawa A, Matsuda T, Ikegami N, Funaki A, Yamada M, Kamemoto K, et al.
J Sports Med Phys Fitness
. 2023 Sep;
63(11):1165-1174.
PMID: 37712928
Background: Low-volume high-intensity interval training (HIIT) for weight loss has become prevalent in recent years, with increased excess post-exercise oxygen consumption (EPOC) as the mechanism. However, the influence of the...
5.
Kawabe N, Matsuoka K, Komeda K, Muraki N, Takaba M, Togami Y, et al.
Oncol Lett
. 2023 Aug;
26(3):391.
PMID: 37600329
Grainyhead-like 2 (GRHL2) is a transcription factor that suppresses epithelial-to-mesenchymal transition (EMT). It has been previously shown that GRHL2 can confer both oncogenic and tumor-suppressive roles in human cancers, including...
6.
Contrast-enhanced ultrasound imaging for monitoring the efficacy of near-infrared photoimmunotherapy
Matsuoka K, Yamada M, Fukatsu N, Goto K, Shimizu M, Kato A, et al.
EBioMedicine
. 2023 Aug;
95:104737.
PMID: 37558554
Background: Near-infrared photoimmunotherapy (NIR-PIT) is a promising cancer therapy combining NIR-light irradiation with an antibody and IR700DX, a light-sensitive substance, to destroy tumours. However, homogeneous irradiation is difficult because the...
7.
Yamada M, Matsuoka K, Sato M, Sato K
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839882
Current immunotherapies aim to modulate the balance among different immune cell populations, thereby controlling immune reactions. However, they often cause immune overactivation or over-suppression, which makes them difficult to control....
8.
Ishikawa A, Matsuda T, Gam H, Kanno M, Yamada M, Ikegami N, et al.
Nutrients
. 2022 Oct;
14(19).
PMID: 36235549
In women, fat oxidation during exercise changes with the menstrual cycle. This study aimed to investigate the effect of green tea extract (GTE) ingestion on fat oxidation during exercise depending...
9.
Yamada M, Ishikawa A, Muramatsu S, Furuishi T, Onuki Y, Fukuzawa K, et al.
Pharmaceuticals (Basel)
. 2022 Aug;
15(8).
PMID: 36015152
Moisture-activated dry granulation (MADG) is an eco-friendly granulation method that uses a small amount of water and insoluble excipients to absorb moisture. MADG is expected to improve productivity and reduce...
10.
Funaki A, Gam H, Matsuda T, Ishikawa A, Yamada M, Ikegami N, et al.
Int J Environ Res Public Health
. 2022 Aug;
19(15).
PMID: 35954552
We investigated the influence of the menstrual cycle (MC) on leukocyte response after exercise-induced muscle damage (EIMD). During the early follicular (E-FP, = 12) or mid-luteal phase (M-LP, = 12),...